![Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review | Journal of the American College of Cardiology Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/c0d233ba-f365-4c7d-a547-81a382257070/fx1.jpg)
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review | Journal of the American College of Cardiology
![Triple antithrombotic therapy after ACS and PCI in patients on chronic oral anticoagulation: update | Heart Triple antithrombotic therapy after ACS and PCI in patients on chronic oral anticoagulation: update | Heart](https://heart.bmj.com/content/heartjnl/104/23/1976/F2.large.jpg)
Triple antithrombotic therapy after ACS and PCI in patients on chronic oral anticoagulation: update | Heart
![Cardiovascular Medicine - Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease Cardiovascular Medicine - Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease](https://cardiovascmed.ch/rsrc/ji?tx_swajournal_image%5Baction%5D=index&tx_swajournal_image%5Bcontroller%5D=Image&tx_swajournal_image%5Bheight%5D=780&tx_swajournal_image%5Bidentifier%5D=cvm.2019.02024&tx_swajournal_image%5Bjournal%5D=ezm_cvm&tx_swajournal_image%5Blanguage%5D=en&tx_swajournal_image%5Bmode%5D=view&tx_swajournal_image%5Bresource%5D=http%3A%2F%2Fprodclient.emh02.snowflakehosting.ch%2Fapi%2Ffile%2Fproduction%2F78%2F7889c2b44e95172b3e990e4e71a20dba50f6de90%2F02024_f3_conv.jpg&tx_swajournal_image%5Bscale%5D=ratio&tx_swajournal_image%5Btype%5D=article&tx_swajournal_image%5Bwidth%5D=780)
Cardiovascular Medicine - Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease
![Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI.,JACC: Cardiovascular Interventions - X-MOL Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI.,JACC: Cardiovascular Interventions - X-MOL](https://xpic.x-mol.com/20190820%2F10.1016_j.jcin.2019.05.050.jpg)
Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI.,JACC: Cardiovascular Interventions - X-MOL
![Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - ScienceDirect Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0914508718302478-gr2.jpg)
Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - ScienceDirect
![Fernando de la Guía 🩺 on Twitter: "Atrial fibrillation patients undergoing PCI for NSTE-ACS. Triple therapy (N)OAC + DAPT up to 1 week (in hospital) and after... 🧐 and finally (N)OAC alone! # Fernando de la Guía 🩺 on Twitter: "Atrial fibrillation patients undergoing PCI for NSTE-ACS. Triple therapy (N)OAC + DAPT up to 1 week (in hospital) and after... 🧐 and finally (N)OAC alone! #](https://pbs.twimg.com/media/EgqPy5SXYAANEN5.jpg)
Fernando de la Guía 🩺 on Twitter: "Atrial fibrillation patients undergoing PCI for NSTE-ACS. Triple therapy (N)OAC + DAPT up to 1 week (in hospital) and after... 🧐 and finally (N)OAC alone! #
![Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention | Circulation Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention | Circulation](https://www.ahajournals.org/cms/asset/0a2c40b2-6f5f-4714-bac5-93dbbf6f20d4/527fig02.gif)
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention | Circulation
![ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison - ScienceDirect ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109718387369-fx1.jpg)
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison - ScienceDirect
![Frontiers | The Management of Combined Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Particularly Complex Challenge, Especially in the Elderly | Physiology Frontiers | The Management of Combined Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Particularly Complex Challenge, Especially in the Elderly | Physiology](https://www.frontiersin.org/files/Articles/382911/fphys-09-00876-HTML/image_m/fphys-09-00876-g001.jpg)
Frontiers | The Management of Combined Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Particularly Complex Challenge, Especially in the Elderly | Physiology
2016 ACC/AHA Guideline Focused€Update on Duration of Dual€Antiplatelet Therapy in Patients With Coronary Artery Disease
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the
![Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention | Circulation Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention | Circulation](https://www.ahajournals.org/cms/asset/d00d9769-ab77-4f18-8835-bdc2b641cb98/527fig01.gif)
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention | Circulation
![Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis.,JACC: Cardiovascular Interventions - X-MOL Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis.,JACC: Cardiovascular Interventions - X-MOL](https://xpic.x-mol.com/20191204%2F10.1016_j.jcin.2019.08.039.jpg)
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis.,JACC: Cardiovascular Interventions - X-MOL
Triple Antithrombotic Therapy in Atrial Fibrillation Patients With an Indication for Oral Anticoagulation Undergoing Percutaneou
![Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy – “Real World” Experience - ScienceDirect Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy – “Real World” Experience - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0033062018300306-gr1.jpg)